113 related articles for article (PubMed ID: 31814441)
1. Non-inferiority designs comparing placebo to a proven therapy for childhood pneumonia in low-resource settings.
May S; Brown SP; Schmicker RH; Emerson SS; Nkwopara E; Ginsburg AS
Clin Trials; 2020 Apr; 17(2):129-137. PubMed ID: 31814441
[TBL] [Abstract][Full Text] [Related]
2. Placebo vs Amoxicillin for Nonsevere Fast-Breathing Pneumonia in Malawian Children Aged 2 to 59 Months: A Double-blind, Randomized Clinical Noninferiority Trial.
Ginsburg AS; Mvalo T; Nkwopara E; McCollum ED; Ndamala CB; Schmicker R; Phiri A; Lufesi N; Izadnegahdar R; May S
JAMA Pediatr; 2019 Jan; 173(1):21-28. PubMed ID: 30419120
[TBL] [Abstract][Full Text] [Related]
3. Methods for conducting a double-blind randomized controlled clinical trial of three days versus five days of amoxicillin dispersible tablets for chest indrawing childhood pneumonia among children two to 59 months of age in Lilongwe, Malawi: a study protocol.
Ginsburg AS; May SJ; Nkwopara E; Ambler G; McCollum ED; Mvalo T; Phiri A; Lufesi N; Sadruddin S
BMC Infect Dis; 2018 Sep; 18(1):476. PubMed ID: 30241517
[TBL] [Abstract][Full Text] [Related]
4. A double blind community-based randomized trial of amoxicillin versus placebo for fast breathing pneumonia in children aged 2-59 months in Karachi, Pakistan (RETAPP).
Jehan F; Nisar MI; Kerai S; Brown N; Balouch B; Hyder Z; Ambler G; Ginsburg AS; Zaidi AK
BMC Infect Dis; 2016 Jan; 16():13. PubMed ID: 26758747
[TBL] [Abstract][Full Text] [Related]
5. Analysis of serious adverse events in a paediatric fast breathing pneumonia clinical trial in Malawi.
Nkwopara E; Schmicker R; Mvalo T; Phiri M; Phiri A; Couasnon M; McCollum ED; Ginsburg AS
BMJ Open Respir Res; 2019; 6(1):e000415. PubMed ID: 31548894
[TBL] [Abstract][Full Text] [Related]
6. Randomized Trial of Amoxicillin for Pneumonia in Pakistan.
Jehan F; Nisar I; Kerai S; Balouch B; Brown N; Rahman N; Rizvi A; Shafiq Y; Zaidi AKM
N Engl J Med; 2020 Jul; 383(1):24-34. PubMed ID: 32609980
[TBL] [Abstract][Full Text] [Related]
7. Geographically linked risk factors for enrolment into a fast breathing child pneumonia trial in Lilongwe, Malawi: an Innovative Treatments in Pneumonia (ITIP) secondary analysis.
Nkwopara E; Schmicker R; Mvalo T; May S; Ginsburg AS
BMJ Open Respir Res; 2019; 6(1):e000414. PubMed ID: 31179007
[TBL] [Abstract][Full Text] [Related]
8. Analysis of serious adverse events in a pediatric community-acquired pneumonia randomized clinical trial in Malawi.
Ginsburg AS; May S
Sci Rep; 2022 Mar; 12(1):3538. PubMed ID: 35241775
[TBL] [Abstract][Full Text] [Related]
9. Development of a prognostic risk score to aid antibiotic decision-making for children aged 2-59 months with World Health Organization fast breathing pneumonia in Malawi: An Innovative Treatments in Pneumonia (ITIP) secondary analysis.
McCollum ED; Brown SP; Nkwopara E; Mvalo T; May S; Ginsburg AS
PLoS One; 2019; 14(6):e0214583. PubMed ID: 31220085
[TBL] [Abstract][Full Text] [Related]
10. Should fast breathing pneumonia cases be treated with antibiotics? The scientific rationale for revisiting management in Low and Middle income countries.
Jehan F; Nisar I; Kerai S; Brown N; Ambler G; Zaidi AKM
Int J Infect Dis; 2019 Aug; 85():64-66. PubMed ID: 31176034
[TBL] [Abstract][Full Text] [Related]
11. Community-based amoxicillin treatment for fast breathing pneumonia in young infants 7-59 days old: a cluster randomised trial in rural Bangladesh, Ethiopia, India and Malawi.
; Nisar YB
BMJ Glob Health; 2021 Aug; 6(8):. PubMed ID: 34417274
[TBL] [Abstract][Full Text] [Related]
12. Can child pneumonia in low-resource settings be treated without antibiotics? A systematic review & meta-analysis.
Walker PJ; Wilkes C; Duke T; Graham HR;
J Glob Health; 2022 Nov; 12():10007. PubMed ID: 36370376
[TBL] [Abstract][Full Text] [Related]
13. Amoxicillin for 3 or 5 Days for Chest-Indrawing Pneumonia in Malawian Children.
Ginsburg AS; Mvalo T; Nkwopara E; McCollum ED; Phiri M; Schmicker R; Hwang J; Ndamala CB; Phiri A; Lufesi N; May S
N Engl J Med; 2020 Jul; 383(1):13-23. PubMed ID: 32609979
[TBL] [Abstract][Full Text] [Related]
14. Superiority and non-inferiority: two sides of the same coin?
Dunn DT; Copas AJ; Brocklehurst P
Trials; 2018 Sep; 19(1):499. PubMed ID: 30223881
[TBL] [Abstract][Full Text] [Related]
15. Comparison of oral amoxicillin with placebo for the treatment of world health organization-defined nonsevere pneumonia in children aged 2-59 months: a multicenter, double-blind, randomized, placebo-controlled trial in pakistan.
Hazir T; Nisar YB; Abbasi S; Ashraf YP; Khurshid J; Tariq P; Asghar R; Murtaza A; Masood T; Maqbool S
Clin Infect Dis; 2011 Feb; 52(3):293-300. PubMed ID: 21189270
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of oral amoxicillin-clavulanate or azithromycin for non-severe respiratory exacerbations in children with bronchiectasis (BEST-1): a multicentre, three-arm, double-blind, randomised placebo-controlled trial.
Goyal V; Grimwood K; Ware RS; Byrnes CA; Morris PS; Masters IB; McCallum GB; Binks MJ; Smith-Vaughan H; O'Grady KF; Champion A; Buntain HM; Schultz A; Chatfield M; Torzillo PJ; Chang AB
Lancet Respir Med; 2019 Sep; 7(9):791-801. PubMed ID: 31427252
[TBL] [Abstract][Full Text] [Related]
17. A randomized controlled trial of hospital versus home based therapy with oral amoxicillin for severe pneumonia in children aged 3 - 59 months: The IndiaCLEN Severe Pneumonia Oral Therapy (ISPOT) Study.
Patel AB; Bang A; Singh M; Dhande L; Chelliah LR; Malik A; Khadse S;
BMC Pediatr; 2015 Nov; 15():186. PubMed ID: 26577943
[TBL] [Abstract][Full Text] [Related]
18. Systematic review on antibiotic therapy for pneumonia in children between 2 and 59 months of age.
Lassi ZS; Das JK; Haider SW; Salam RA; Qazi SA; Bhutta ZA
Arch Dis Child; 2014 Jul; 99(7):687-93. PubMed ID: 24431417
[TBL] [Abstract][Full Text] [Related]
19. Non-inferiority trials: design concepts and issues - the encounters of academic consultants in statistics.
D'Agostino RB; Massaro JM; Sullivan LM
Stat Med; 2003 Jan; 22(2):169-86. PubMed ID: 12520555
[TBL] [Abstract][Full Text] [Related]
20. Ambulatory short-course high-dose oral amoxicillin for treatment of severe pneumonia in children: a randomised equivalency trial.
Hazir T; Fox LM; Nisar YB; Fox MP; Ashraf YP; MacLeod WB; Ramzan A; Maqbool S; Masood T; Hussain W; Murtaza A; Khawar N; Tariq P; Asghar R; Simon JL; Thea DM; Qazi SA;
Lancet; 2008 Jan; 371(9606):49-56. PubMed ID: 18177775
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
